Meds & supplements › Rozanolixizumab
Medicine · Neonatal Fc Receptor Blocker
RYSTIGGO is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
The following clinically significant adverse reactions are discussed in greater detail in other sections of the labeling:
None.
Store vials refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until the time of use. Do not freeze. Do not shake.
If needed, vials may be stored at room temperature up to 77°F (25°C) for a single period of up to 20 days in the original carton to protect the vial from light. Once a vial has been stored at room temperature, it should not be returned to the refrigerator. The discard date is 20 days after removal of the vial from the refrigerator. Write the discard date in the space provided on the carton. Discard the vial if not used within 20 days or if the expiration date has passed, whichever occurs first.
sofidex [Internet]. Daloreum; c2026. Rozanolixizumab; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/rozanolixizumab
sofidex. (2026, August 3). Rozanolixizumab. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/rozanolixizumab
Rozanolixizumab. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/rozanolixizumab
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.